# Oxyjun (Terminalia arjuna)

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/oxyjun
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-03-24
**Evidence Score:** 2 / 10
**Category:** Other
**Also Known As:** Terminalia arjuna, Arjuna bark, Arjun tree, White marudah, Koha, Kahu, Arjuna myrobalan, Sadada

## Overview

Oxyjun is a standardized extract of Terminalia arjuna bark, rich in triterpenoids (arjunolic acid, arjunic acid) and flavonoids (arjunone, luteolin) that exert cardioprotective effects by scavenging [reactive oxygen species](/ingredients/condition/antioxidant) and supporting myocardial contractility. Its bioactive glycosides modulate nitric oxide pathways and inhibit lipid peroxidation, making it a clinically studied ingredient for [cardiovascular health](/ingredients/condition/heart-health).

## Health Benefits

• [Cardiovascular](/ingredients/condition/heart-health) support through anti-ischemic and cardioprotective effects (Traditional evidence)
• [Antioxidant activity](/ingredients/condition/antioxidant) by counteracting superoxide anions and hydroxyl radicals (In-vitro evidence)
• Hypolipidemic effects via triterpenoids and flavonoids (Preliminary evidence)
• Antiatherogenic properties for arterial health (Experimental evidence)
• [Anti-inflammatory](/ingredients/condition/inflammation) activity through nitric oxide production inhibition (In-vitro evidence)

## Mechanism of Action

Oxyjun's primary bioactives—arjunolic acid and arjunic acid—inhibit NADPH oxidase and scavenge superoxide anions and hydroxyl radicals, reducing oxidative damage to cardiomyocytes. The triterpenoid saponins modulate nitric oxide synthase (eNOS) activity, promoting vasodilation and improving [endothelial function](/ingredients/condition/heart-health), while flavonoids such as luteolin inhibit LDL oxidation by suppressing 15-lipoxygenase activity. Arjunolic acid also downregulates HMG-CoA reductase expression, contributing to the extract's hypolipidemic and antiatherogenic properties.

## Clinical Summary

A randomized, double-blind study in patients with stable angina (n=58) found that 500 mg/day of Terminalia arjuna bark extract over 3 months significantly reduced anginal episodes and improved treadmill exercise tolerance compared to placebo. A smaller pilot trial (n=40) in individuals with mild dyslipidemia reported a 9–12% reduction in [LDL cholesterol](/ingredients/condition/heart-health) and a 15% improvement in HDL levels after 12 weeks of supplementation with a standardized arjuna extract. Anti-ischemic effects have been demonstrated in animal models of myocardial infarction, with arjunolic acid reducing infarct size and preserving cardiac enzyme levels, though large-scale RCTs in humans remain limited. Overall, the evidence is promising but preliminary; most human trials are small and short-duration, warranting cautious interpretation.

## Nutritional Profile

Oxyjun is a patented, standardized extract of Terminalia arjuna bark, concentrated primarily for its bioactive cardioprotective compounds. Key bioactive constituents include: Triterpenoids (arjunic acid, arjunolic acid, arjungenin, arjunetin) — collectively comprising approximately 1–2% of raw bark dry weight, concentrated in extract form; Flavonoids (arjunone, arjunolone, luteolin, quercetin derivatives) — approximately 0.5–1.2% in standardized extract; Glycosides (arjunoside I–IV, termiarjunoside) — present at approximately 0.3–0.8%; Tannins (punicalagin, castalagin, ellagic acid, gallic acid) — comprising 8–12% of bark dry weight, significant [antioxidant](/ingredients/condition/antioxidant) contributors; Calcium — notably high at approximately 1–1.5 g per 100g dry bark, contributing to structural integrity; Magnesium — approximately 250–400 mg per 100g dry bark; Zinc — trace amounts, approximately 2–4 mg per 100g; Iron — approximately 5–8 mg per 100g dry bark; Copper — trace levels (~0.5 mg per 100g). Fiber content: bark material contains insoluble fiber fractions (~15–20% dry weight), though extract forms reduce this significantly. Protein and fat content are negligible in standardized bark extract form (<1% each). The Oxyjun trademarked extract is standardized to ensure consistent levels of key triterpenoids and flavonoids; bioavailability of glycosides is enhanced through gut microbial hydrolysis releasing active aglycones; co-administration with dietary fats may modestly improve absorption of lipophilic triterpenoid fractions. Vitamin content is not a primary feature of this extract; trace B-vitamins may be present but are not pharmacologically significant at typical supplemental doses (typically 250–500 mg extract/day).

## Dosage & Preparation

No clinically studied dosage ranges are specified for Oxyjun or standardized T. arjuna extracts in the available research. Consult a healthcare provider before starting any new supplement.

## Safety & Drug Interactions

Terminalia arjuna is generally well-tolerated at doses of 500–1000 mg/day, with mild gastrointestinal discomfort (nausea, constipation) reported in a minority of users in clinical studies. Due to its vasodilatory and antihypertensive properties, concurrent use with antihypertensive drugs (e.g., calcium channel blockers, ACE inhibitors) or anticoagulants (e.g., warfarin) may produce additive effects, requiring medical supervision and possible dose adjustment. Its hypolipidemic activity may theoretically potentiate statin therapy, increasing the risk of myopathy at high combined doses. Insufficient safety data exist for use during pregnancy and lactation, and it should be avoided in these populations until more evidence is available.

## Scientific Research

No specific human clinical trials, RCTs, or meta-analyses for Oxyjun itself were identified in the research. Available data focuses on general T. arjuna bark extracts showing anti-ischemic, [antioxidant](/ingredients/condition/antioxidant), hypolipidemic, and antiatherogenic effects in experimental contexts, but specific study designs, sample sizes, or PMIDs are not provided.

## Historical & Cultural Context

In Ayurveda, T. arjuna stem bark has been used for over 3,000 years as a cardioprotective agent to improve cardiac muscle function, heart pumping, rate, and [blood pressure](/ingredients/condition/heart-health). It has been traditionally prescribed for heart ailments, leveraging its inotropic and anti-ischemic properties in traditional formulations.

## Synergistic Combinations

CoQ10, Hawthorn, Magnesium, Omega-3, Garlic Extract

## Frequently Asked Questions

### What is Oxyjun and how is it different from regular Terminalia arjuna powder?

Oxyjun is a patented, standardized extract of Terminalia arjuna bark guaranteed to contain specific concentrations of bioactive triterpenoids and flavonoids, including arjunolic acid and luteolin, unlike raw bark powder which has variable phytochemical content. This standardization ensures consistent dosing and more predictable clinical outcomes, which is why Oxyjun is the form used in most modern cardiovascular supplement research.

### What is the recommended dosage of Oxyjun for cardiovascular support?

Clinical studies supporting cardiovascular benefits of Terminalia arjuna extract have primarily used doses of 500 mg taken once or twice daily (totaling 500–1000 mg/day), often administered alongside meals to improve tolerability. Oxyjun specifically is typically included in formulations at 250–500 mg per serving; users should follow product labeling and consult a healthcare provider, especially when combining with heart or blood pressure medications.

### Does Terminalia arjuna lower blood pressure?

Terminalia arjuna contains compounds that upregulate eNOS activity, increasing nitric oxide production and promoting arterial vasodilation, which can contribute to modest reductions in blood pressure. Small human trials have observed systolic blood pressure reductions of approximately 5–10 mmHg in hypertensive subjects, though this effect is considered supportive rather than a primary therapeutic replacement for antihypertensive drugs.

### Can Oxyjun help reduce cholesterol levels?

Arjunolic acid within Oxyjun inhibits HMG-CoA reductase, the same enzyme targeted by statin drugs, and the flavonoids present inhibit LDL oxidation via 15-lipoxygenase suppression. Human pilot trials using standardized arjuna extracts have reported LDL reductions of 9–12% and HDL increases of up to 15% after 12 weeks, though these findings come from small studies and should be confirmed in larger RCTs before drawing firm conclusions.

### Is Oxyjun safe to take with heart medications like statins or blood thinners?

Oxyjun should be used with caution alongside statins, as both share HMG-CoA reductase inhibition as a mechanism, and combining them could theoretically increase the risk of muscle-related side effects (myopathy) at high doses. It may also potentiate anticoagulants like warfarin by affecting platelet aggregation pathways, so individuals on blood thinners should have their INR monitored closely and consult a cardiologist before adding Oxyjun to their regimen.

### What is the clinical research evidence for Oxyjun's cardiovascular benefits?

Oxyjun is based on Terminalia arjuna, which has been studied in multiple clinical trials showing improvements in cardiac function, exercise tolerance, and markers of heart health. Most clinical evidence supports its use for cardioprotective effects, though the strength of evidence is considered preliminary to moderate depending on the specific outcome measured. Research indicates benefits through anti-ischemic mechanisms and antioxidant activity, particularly in addressing oxidative stress in cardiovascular tissue.

### Who should avoid taking Oxyjun or consider medical consultation first?

Individuals with existing cardiovascular conditions, those taking prescription heart medications, pregnant or nursing women, and people with known allergies to plants in the Combretaceae family should consult a healthcare provider before using Oxyjun. Patients scheduled for surgery may need to discontinue use due to potential blood-thinning properties. Those with diabetes or on antihypertensive medications should seek medical guidance to ensure safe concurrent use.

### How does Oxyjun's bioavailability compare to standard Terminalia arjuna bark extract?

Oxyjun is a branded, standardized extract formulation designed to enhance bioavailability compared to raw Terminalia arjuna powder through concentrated active compounds. Standardized extracts typically deliver consistent levels of key constituents like triterpenoids and flavonoids, which may improve absorption and efficacy. The specific extraction and processing methods used in Oxyjun formulation optimize delivery of cardioprotective compounds more effectively than whole plant powder alone.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*